2rqb: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
{{Seed}}
[[Image:2rqb.png|left|200px]]
<!--
The line below this paragraph, containing "STRUCTURE_2rqb", creates the "Structure Box" on the page.
You may change the PDB parameter (which sets the PDB file loaded into the applet)
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
or leave the SCENE parameter empty for the default display.
-->
{{STRUCTURE_2rqb|  PDB=2rqb  |  SCENE=  }}  
{{STRUCTURE_2rqb|  PDB=2rqb  |  SCENE=  }}  
===Solution structure of MDA5 CTD===
===Solution structure of MDA5 CTD===
{{ABSTRACT_PUBMED_19380577}}


==Disease==
[[http://www.uniprot.org/uniprot/IFIH1_HUMAN IFIH1_HUMAN]] Genetic variation in IFIH1 is associated with diabetes mellitus insulin-dependent type 19 (IDDM19) [MIM:[http://omim.org/entry/610155 610155]]. A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical fetaures are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.<ref>PMID:16699517</ref>  Note=IFIH1 is the CADM-140 autoantigen, involved in clinically amyopathic dermatomyositis (CADM). This is a chronic inflammatory disorder that shows typical skin manifestations of dermatomyositis but has no or little evidence of clinical myositis. Anti-CADM-140 antibodies appear to be specific to dermatomyositis, especially CADM. Patients with anti-CADM-140 antibodies frequently develop life-threatening acute progressive interstitial lung disease (ILD).<ref>PMID:19565506</ref><ref>PMID:20015976</ref>


<!--
==Function==
The line below this paragraph, {{ABSTRACT_PUBMED_19380577}}, adds the Publication Abstract to the page
[[http://www.uniprot.org/uniprot/IFIH1_HUMAN IFIH1_HUMAN]] Innate immune receptor which acts as a cytoplasmic sensor of viral nucleic acids and plays a major role in sensing viral infection and in the activation of a cascade of antiviral responses including the induction of type I interferons and proinflammatory cytokines. Its ligands include mRNA lacking 2'-O-methylation at their 5' cap and long-dsRNA (>1 kb in length). Upon ligand binding it associates with mitochondria antiviral signaling protein (MAVS/IPS1) which activates the IKK-related kinases: TBK1 and IKBKE which phosphorylate interferon regulatory factors: IRF3 and IRF7 which in turn activate transcription of antiviral immunological genes, including interferons (IFNs); IFN-alpha and IFN-beta. Responsible for detecting the Picornaviridae family members such as encephalomyocarditis virus (EMCV) and mengo encephalomyocarditis virus (ENMG). Can also detect other viruses such as dengue virus (DENV), west Nile virus (WNV), and reovirus. Also involved in antiviral signaling in response to viruses containing a dsDNA genome, such as vaccinia virus. Plays an important role in amplifying innate immune signaling through recognition of RNA metabolites that are produced during virus infection by ribonuclease L (RNase L). May play an important role in enhancing natural killer cell function and may be involved in growth inhibition and apoptosis in several tumor cell lines.<ref>PMID:14645903</ref><ref>PMID:19211564</ref><ref>PMID:19656871</ref><ref>PMID:21742966</ref><ref>PMID:21217758</ref>  
(as it appears on PubMed at http://www.pubmed.gov), where 19380577 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_19380577}}


==About this Structure==
==About this Structure==
2RQB is a 1 chain structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2RQB OCA].  
[[2rqb]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2RQB OCA].  


==Reference==
==Reference==
<ref group="xtra">PMID:19380577</ref><references group="xtra"/>
<ref group="xtra">PMID:019380577</ref><references group="xtra"/><references/>
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Fujita, T.]]
[[Category: Fujita, T.]]
Line 36: Line 26:
[[Category: Tsuduki, N.]]
[[Category: Tsuduki, N.]]
[[Category: Yoneyama, M.]]
[[Category: Yoneyama, M.]]
[[Category: Alternative splicing]]
[[Category: Antiviral defense]]
[[Category: Antiviral defense]]
[[Category: Atp-binding]]
[[Category: Atp-binding]]
[[Category: Cytoplasm]]
[[Category: Diabetes mellitus]]
[[Category: Diabetes mellitus]]
[[Category: Helicase]]
[[Category: Helicase]]
Line 49: Line 37:
[[Category: Nucleus]]
[[Category: Nucleus]]
[[Category: Phosphoprotein]]
[[Category: Phosphoprotein]]
[[Category: Polymorphism]]
[[Category: Rna binding protein]]
[[Category: Rna binding protein]]
[[Category: Rna-binding]]
[[Category: Rna-binding]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jul  8 20:03:12 2009''